Peregrine Asset Advisers, Inc. Eli Lilly & CO Transaction History
Peregrine Asset Advisers, Inc.
- $284 Million
- Q3 2024
A detailed history of Peregrine Asset Advisers, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Peregrine Asset Advisers, Inc. holds 5,737 shares of LLY stock, worth $4.59 Million. This represents 1.79% of its overall portfolio holdings.
Number of Shares
5,737
Previous 7,596
24.47%
Holding current value
$4.59 Million
Previous $6.88 Million
26.1%
% of portfolio
1.79%
Previous 2.82%
Shares
11 transactions
Others Institutions Holding LLY
# of Institutions
4,016Shares Held
739MCall Options Held
8.27MPut Options Held
10.5M-
Lilly Endowment Inc Indianapolis, IN96.9MShares$77.5 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA73.8MShares$59 Billion1.2% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$52.7 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$41.1 Billion29.2% of portfolio
-
State Street Corp Boston, MA33.9MShares$27.1 Billion1.24% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $760B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...